Article
NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway
1 Jan 2023
Abstract excerpt
Background: NAT10 (N-acetyltransferase 10) is a newly identified novel acetyltransferase. Abnormal expression of NAT10 is associated with several human disorders, including cancer, autoimmune diseases, and cardiovascular disease. This study aimed to investigate the role of NAT10 in promoting lung cancer malignant progression through the NF-κB (nuclear factor κB) signaling pathway. Methods: Cells lines BEAS-2B,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
